within Pharmacolibrary.Drugs.ATC.A;

model A01AD02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.87,
    Cl             = 4.9999999999999996e-06,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.01155,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A01AD02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Benzydamine is a non-steroidal anti-inflammatory drug (NSAID) with local analgesic and anti-inflammatory properties. It is primarily used in topical formulations, such as mouthwashes and sprays, for the symptomatic treatment of pain and irritation in the mouth and throat, including sore throat, oral mucositis, and pharyngitis. Benzydamine is approved and widely used in many countries, especially in Europe.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults following oral administration, due to lack of published, peer-reviewed compartmental PK model parameters for benzydamine.</p><h4>References</h4><ol><li><p>Chasseaud, LF, &amp; Catanese, B (1985). Pharmacokinetics of benzydamine. <i>International journal of tissue reactions</i> 7(3) 195–204. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/4044147/\">https://pubmed.ncbi.nlm.nih.gov/4044147</a></p></li><li><p>Baldock, GA, et al., &amp; Catanese, B (1991). Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects. <i>Biopharmaceutics &amp; drug disposition</i> 12(7) 481–492. DOI:<a href=\"https://doi.org/10.1002/bdd.2510120702\">10.1002/bdd.2510120702</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1932611/\">https://pubmed.ncbi.nlm.nih.gov/1932611</a></p></li><li><p>Schoenwald, RD, et al., &amp; Catanese, B (1987). Pharmacokinetics of benzydamine. <i>International journal of tissue reactions</i> 9(2) 93–97. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3610518/\">https://pubmed.ncbi.nlm.nih.gov/3610518</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A01AD02;
